Global Transdermal Drug Delivery System Market Research Report 2020 by Manufacturers, Regions, Types and Applications

In this report,in the last several years, global market of Transdermal Drug Delivery System developed rapidly, with an average sales growth rate of 13.4%. In 2016, global revenue of Transdermal Drug Delivery System was nearly 8000 million USD; the actual production is about 13300 million units.

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. The unprecedented global shift in the adoption of unhealthy lifestyles is to be responsible for the high prevalence of chronic diseases, such as cancer and diabetes, which is expected to drive the clinical urgency to incorporate transdermal drug delivery systems in the future treatments. Moreover, the rising geriatric population base, which is highly susceptible to developing the aforementioned chronic diseases are expected to propel the demand for highly efficacious pharmacological drugs.

The classification of Transdermal Drug Delivery System includes Fentanyl, Nitroglycerin, Estradiol, Nicotine and Other, and the revenue proportion of Fentanyl in 2016 was about 31%.

Transdermal Drug Delivery System can be used for OTC and Rx. The most proportion of Transdermal Drug Delivery System is OTC, and the sales proportion was about 83% in 2016.

Market competition is intense. Hisamitsu, Mylan, Johnson & Johnson, Actavis, etc. are the leaders of the industry.

North America was the largest sales place, with revenue market share nearly 41% in 2016. Following North America, Europe is the second largest sales place. China and Japan are also important sales regions for Transdermal Drug Delivery System.

Geographically, global Transdermal Drug Delivery System market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
UCB
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Other

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Transdermal Drug Delivery System for each application, including
OTC
Rx
Production, consumption, revenue, market share and growth rate are the key targets for Transdermal Drug Delivery System from 2014 to 2026 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Transdermal Drug Delivery System Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Transdermal Drug Delivery System Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Transdermal Drug Delivery System Market Performance
2.3 USA Transdermal Drug Delivery System Market Performance
2.4 Europe Transdermal Drug Delivery System Market Performance
2.5 Japan Transdermal Drug Delivery System Market Performance
2.6 Korea Transdermal Drug Delivery System Market Performance
2.7 India Transdermal Drug Delivery System Market Performance
2.8 Southeast Asia Transdermal Drug Delivery System Market Performance
2.9 South America Transdermal Drug Delivery System Market Performance
3 Global Transdermal Drug Delivery System Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Transdermal Drug Delivery System Market Performance (Volume)
3.3 USA Transdermal Drug Delivery System Market Performance (Volume)
3.4 Europe Transdermal Drug Delivery System Market Performance (Volume)
3.5 Japan Transdermal Drug Delivery System Market Performance (Volume)
3.6 Korea Transdermal Drug Delivery System Market Performance (Volume)
3.7 India Transdermal Drug Delivery System Market Performance (Volume)
3.8 Southeast Asia Transdermal Drug Delivery System Market Performance (Volume)
3.9 South America Transdermal Drug Delivery System Market Performance (Volume)
4 Competitive Analysis
4.1 Hisamitsu
4.1.1 Hisamitsu Profiles
4.1.2 Hisamitsu Product Information
4.1.3 Hisamitsu Transdermal Drug Delivery System Production, Revenue, Price and Gross Margin
4.1.4 Hisamitsu Transdermal Drug Delivery System Business Performance
4.1.5 SWOT Analysis
4.2 Mylan
4.2.1 Mylan Profiles
4.2.2 Mylan Product Information
4.2.3 Mylan Transdermal Drug Delivery System Production, Revenue, Price and Gross Margin
4.2.4 Mylan Transdermal Drug Delivery System Business Performance
4.2.5 SWOT Analysis
4.3 GSK
4.3.1 GSK Profiles
4.3.2 GSK Product Information
4.3.3 GSK Transdermal Drug Delivery System Production, Revenue, Price and Gross Margin
4.3.4 GSK Transdermal Drug Delivery System Business Performance
4.3.5 SWOT Analysis
4.4 Novartis
4.4.1 Novartis Profiles
4.4.2 Novartis Product Information
4.4.3 Novartis Transdermal Drug Delivery System Production, Revenue, Price and Gross Margin
4.4.4 Novartis Transdermal Drug Delivery System Business Performance
4.4.5 SWOT Analysis
4.5 Teve (Actavis)
4.5.1 Teve (Actavis) Profiles
4.5.2 Teve (Actavis) Product Information
4.5.3 Teve (Actavis) Transdermal Drug Delivery System Production, Revenue, Price and Gross Margin
4.5.4 Teve (Actavis) Transdermal Drug Delivery System Business Performance
4.5.5 SWOT Analysis
4.6 Johnson & Johnson
4.6.1 Johnson & Johnson Profiles
4.6.2 Johnson & Johnson Product Information
4.6.3 Johnson & Johnson Transdermal Drug Delivery System Production, Revenue, Price and Gross Margin
4.6.4 Johnson & Johnson Transdermal Drug Delivery System Business Performance
4.6.5 SWOT Analysis
4.7 UCB
4.7.1 UCB Profiles
4.7.2 UCB Product Information
4.7.3 UCB Transdermal Drug Delivery System Production, Revenue, Price and Gross Margin
4.7.4 UCB Transdermal Drug Delivery System Business Performance
4.7.5 SWOT Analysis
4.8 Teikoku Seiyaku
4.8.1 Teikoku Seiyaku Profiles
4.8.2 Teikoku Seiyaku Product Information
4.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Production, Revenue, Price and Gross Margin
4.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Business Performance
4.8.5 SWOT Analysis
4.9 Bayer
4.9.1 Bayer Profiles
4.9.2 Bayer Product Information
4.9.3 Bayer Transdermal Drug Delivery System Production, Revenue, Price and Gross Margin
4.9.4 Bayer Transdermal Drug Delivery System Business Performance
4.9.5 SWOT Analysis
4.10 Lingrui
4.10.1 Lingrui Profiles
4.10.2 Lingrui Product Information
4.10.3 Lingrui Transdermal Drug Delivery System Production, Revenue, Price and Gross Margin
4.10.4 Lingrui Transdermal Drug Delivery System Business Performance
4.10.5 SWOT Analysis
4.11 Sanofi
4.12 Qizheng
4.13 Endo
4.14 Huarun 999
4.15 Haw Par
4.16 Nichiban
4.17 Mentholatum Company
4.18 Laboratoires Genevrier
4.19 Other
5 Competitive Landscape
5.1 Global Transdermal Drug Delivery System Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Transdermal Drug Delivery System Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Transdermal Drug Delivery System Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Transdermal Drug Delivery System Market Assessment by Regions
6.1 Global Transdermal Drug Delivery System Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Transdermal Drug Delivery System Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Transdermal Drug Delivery System Price (USD/Unit) by Regions (2014-2020)
6.4 Global Transdermal Drug Delivery System Gross Margin by Regions (2014-2020)
7 Transdermal Drug Delivery System Regional Analysis
7.1 China Transdermal Drug Delivery System Production, Revenue and Growth Rate (2014-2020)
7.2 USA Transdermal Drug Delivery System Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Transdermal Drug Delivery System Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Transdermal Drug Delivery System Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Transdermal Drug Delivery System Production, Revenue and Growth Rate (2014-2020)
7.6 India Transdermal Drug Delivery System Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Transdermal Drug Delivery System Production, Revenue and Growth Rate (2014-2020)
7.8 South America Transdermal Drug Delivery System Production, Revenue and Growth Rate (2014-2020)
8 Global Transdermal Drug Delivery System Consumption Assessment
8.1 Global Transdermal Drug Delivery System Consumption and Market Share by Regions (2014-2020)
8.2 Global Transdermal Drug Delivery System Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Transdermal Drug Delivery System Average Price (USD/Unit) by Regions (2014-2020)
9 Global Transdermal Drug Delivery System Sales Assessment by Regions
9.1 Global Transdermal Drug Delivery System Sales and Sales Value (2014-2020)
9.2 China Transdermal Drug Delivery System Sales and Sales Value (2014-2020)
9.3 USA Transdermal Drug Delivery System Sales and Sales Value (2014-2020)
9.4 Europe Transdermal Drug Delivery System Sales and Sales Value (2014-2020)
9.5 Japan Transdermal Drug Delivery System Sales and Sales Value (2014-2020)
9.6 Korea Transdermal Drug Delivery System Sales and Sales Value (2014-2020)
9.7 India Transdermal Drug Delivery System Sales and Sales Value (2014-2020)
9.8 Southeast Asia Transdermal Drug Delivery System Sales and Sales Value (2014-2020)
9.9 South America Transdermal Drug Delivery System Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2021-2026
12.1 Production and Revenue Forecast 2021-2026
12.1.1 Global Transdermal Drug Delivery System Production and Revenue by Regions 2021-2026
12.1.2 China Transdermal Drug Delivery System Production, Revenue and Growth Rate 2021-2026
12.1.3 USA Transdermal Drug Delivery System Production, Revenue and Growth Rate 2021-2026
12.1.4 Europe Transdermal Drug Delivery System Production, Revenue and Growth Rate 2021-2026
12.1.5 Japan Transdermal Drug Delivery System Production, Revenue and Growth Rate 2021-2026
12.1.6 Korea Transdermal Drug Delivery System Production, Revenue and Growth Rate 2021-2026
12.1.7 India Transdermal Drug Delivery System Production, Revenue and Growth Rate 2021-2026
12.1.8 Southeast Asia Transdermal Drug Delivery System Production, Revenue and Growth Rate 2021-2026
12.1.9 South America Transdermal Drug Delivery System Production, Revenue and Growth Rate 2021-2026
12.2 Sales and Sales Value Forecast 2021-2026
12.2.1 Global Transdermal Drug Delivery System Consumption and Consumption Calue by Regions 2021-2026
12.2.2 Global Transdermal Drug Delivery System Sales and Sales Value Forecast 2021-2026
12.2.3 China Transdermal Drug Delivery System Sales, Sales Value and Growth Rate 2021-2026
12.2.4 USA Transdermal Drug Delivery System Sales and Sales Value Forecast 2021-2026
12.2.5 Europe Transdermal Drug Delivery System Sales and Sales Value Forecast 2021-2026
12.2.6 Japan Transdermal Drug Delivery System Sales and Sales Value Forecast 2021-2026
12.2.7 Korea Transdermal Drug Delivery System Sales and Sales Value Forecast 2021-2026
12.2.8 India Transdermal Drug Delivery System Sales and Sales Value Forecast 2021-2026
12.2.9 Southeast Asia Transdermal Drug Delivery System Sales and Sales Value Forecast 2021-2026
12.2.10 South America Transdermal Drug Delivery System Sales and Sales Value Forecast 2021-2026
12.3 Global Transdermal Drug Delivery System Production and Revenue Forecast by Type 2021-2026
12.3.1 Overall Market Performance
12.3.2 Fentanyl
12.3.3 Nitroglycerin
12.3.4 Estradiol
12.3.5 Nicotine
12.3.6 Other
12.4 Global Transdermal Drug Delivery System Sales Forecast by Application 2021-2026
12.4.1 Overall Market Performance
12.4.2 OTC
12.4.3 Rx
12.5 Global Transdermal Drug Delivery System Price and Gross Margin Forecast
13.5.1 Global Transdermal Drug Delivery System Averages Price Development Trend Forecast 2021-2026
13.5.2 Global Transdermal Drug Delivery System Gross Margin Development Trend Forecast 2021-2026
13 Conclusion